Nyresvigt kliniske forsøg i Florida
16 studier for Nyresvigt søger deltagere på steder i Florida.
Byer i Florida
Officiel studietekst (engelsk)
A Study to Evaluate the Pharmacokinetics and Safety of Golcadomide in Participants With Severe Renal Impairment and End-Stage Renal Disease Compared With Participants With Normal Renal Function
- Panax Clinical Research, Miami Lakes
- Orlando Clinical Research Center OCRC, Orlando
RekruttererFase 1Frivillige med god helbredstilstand velkomne
Alder 18 til 84 · Alle køn · Opdateret 1. okt. 2026 · NCT07763418A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide
- Kailera Clinical Site, Orlando
RekruttererFase 1Frivillige med god helbredstilstand velkomne
Alder 18 til 85 · Alle køn · Opdateret 1. okt. 2026 · NCT07793929Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- - Boca Raton Regional - Research Physicians Network Alliance, Boca Raton
- Nova Clinical Research, LLC, Bradenton
- South Florida Nephrology Group, PA, Coral Springs
- og 14 flere
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT05485961Pivotal Study of the Velocity™ pAVF System
- Vascular and Embolization Specialists, Cocoa
- Azura Vascular Care Jacksonville, Jacksonville
Rekrutterer
Alder 18 til 80 · Alle køn · Opdateret 2. sep. 2026 · NCT07153939A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
- Research Site, Bradenton
- Research Site, Coral Springs
- Research Site, Hollywood
- og 2 flere
RekruttererFase 1/2Frivillige med god helbredstilstand velkomne
Alder 18 til 55 · Alle køn · Opdateret 14. aug. 2026 · NCT06749457Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
- First Coast Cardiovascular Institute Pa, Jacksonville
- Radiology and Imaging Specialists, Lakeland
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 10. aug. 2026 · NCT04634916Incremental Hemodialysis: The TwoPlus Trial
- University of Florida, Jacksonville
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 6. aug. 2026 · NCT05828823Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula
- Sarasota Memorial Hospital, Sarasota
Rekrutterer
Alder 18 til 80 · Alle køn · Opdateret 14. jul. 2026 · NCT06516653AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses
- Mayo Clinic in Florida, Jacksonville
RekruttererFase 1
Alder 18 til 85 · Alle køn · Opdateret 10. jul. 2026 · NCT04392206A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease
- Floridian Clinical Research, Miami Lakes
- Orlando Clinical Research Center, Orlando
RekruttererFase 1
Alder 18 til 85 · Alle køn · Opdateret 16. jun. 2026 · NCT07559396PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis
- Sarasota Memorial Health Care System, Sarasota
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 1. jun. 2026 · NCT06422871Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
- Orlando Health Heart and Vascular Institute, Orlando
Rekrutterer
Alder 18 til 84 · Alle køn · Opdateret 13. apr. 2026 · NCT06190717Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- AdventHealth, Orlando
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 24. mar. 2026 · NCT06217302SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
- Tallahassee Research Institute, Tallahassee
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 17. feb. 2026 · NCT06001827CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
- North Florida/South Georgia Veterans Health System, Gainesville, FL, Gainesville
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 9. jan. 2026 · NCT05931276A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
- Sarasota Memorial Hospital, Sarasota
- University of South Florida, Tampa
Rekrutterer
Alder 18 til 90 · Alle køn · Opdateret 22. dec. 2025 · NCT04671771Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.